4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-033004
Senior VP - Drug Discovery bought 25,000 shares at $1.45 ($36,250)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Babu Yarlagadda S Senior VP - Drug Discovery | 2019-11-18 | Purchase | +25,000 | $1.45 | $36,250 | 155,587 | D |
| Open-market purchases · 25,000 sh · avg $1.45 · $36,250 | |||||||
Loading xslF345X03/form4.xml…